Dear Editor,I have read the article by Shome et al.1 with interest and found
it to be very useful. The application of botulinum toxin in
clinical practice is expanding. The present study also opened a
possible new indication for its use in ophthalmology practice.
However, in this connection I would like to mention a few
things.Botulinum toxin interferes with neuromuscular transmission
by blocking the release of acetylcholine and causes muscular
weakness. Denervation of neuromuscular junction does not
cause permanent damage to nerve terminals and is reversible2
and the functions can be recovered by axonal spouting and
formation of new synaptic contacts, which usually takes two
to three months.3 The mechanism of recovery is not known.
The case in the present study1 improved after giving a single
injection of botulinum toxin, but the patient was followed up
for eight months only. Simon et al.4 found in their study that
the effect of a single injection of botox lasted for three months
to two years, which is longer than the expected duration of
action of the toxin.However, the number of patients in their studies was small.
Although the effects of permanent motor learning and resetting
the point for muscle contraction due to temporary chemo
denervation by the toxin cannot be ruled out, it requires further
study with large number of patients to see the duration of the
effect of a single dose of botulinum toxin and the necessary
dosage, in relieving frontalis-induced eyelid pseudo-retraction
post ptosis surgery.
Authors: Guy J Ben Simon; Sean M Blaydon; Robert M Schwarcz; Tanuj Nakra; Robert A Goldberg; John D McCann Journal: Ophthalmology Date: 2005-05 Impact factor: 12.079